Zdrowie i gospodarka · 22/07/2011
FDA Clears Way for NUVIGIL Tablets to be Approved via Abbreviated New Drug Applications
The FDA has determined that NUVIGIL (armodafinil) Tablets, 100mg and 200mg, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of these tablets via abbreviated new drug applications.
Source: Federal Register — Health and Human ServicesOpen original release →